Orion Oyj (HEL:ORNBV)
Finland
· Delayed Price · Currency is EUR 54.85
-0.15 (-0.27%)
May 9, 2025, 6:29 PM EET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Sale of Goods | 1.16B |
Log In |
Log In |
Log In |
Log In |
| Sale of Goods Growth | 10.30% |
Log In |
Log In |
Log In |
Log In |
| Royalty Income | 292.80M |
Log In |
Log In |
Log In |
Log In |
| Royalty Income Growth | 122.15% |
Log In |
Log In |
Log In |
Log In |
| Milestone Payments | 132.80M |
Log In |
Log In |
Log In |
Log In |
| Milestone Payments Growth | 289.44% |
Log In |
Log In |
Log In |
Log In |
| Animal Health | 131.50M |
Log In |
Log In |
Log In |
Log In |
| Animal Health Growth | 20.75% |
Log In |
Log In |
Log In |
Log In |
| Fermion | 67.30M |
Log In |
Log In |
Log In |
Log In |
| Fermion Growth | -9.18% |
Log In |
Log In |
Log In |
Log In |
| Translation Differences and Other Operations | 300.00K |
Log In |
Log In |
Log In |
Log In |
| Translation Differences and Other Operations Growth | 0% |
Log In |
Log In |
Log In |
Log In |
| Innovative Medicines | 565.50M |
Log In |
Log In |
Log In |
Log In |
| Innovative Medicines Growth | 125.57% |
Log In |
Log In |
Log In |
Log In |
| Branded Products | 294.30M |
Log In |
Log In |
Log In |
Log In |
| Branded Products Growth | 8.36% |
Log In |
Log In |
Log In |
Log In |
| Generics and Consumer Health | 529.40M |
Log In |
Log In |
Log In |
Log In |
| Generics and Consumer Health Growth | 2.86% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Finland | 349.30M |
Log In |
Log In |
Log In |
Log In |
| Finland Growth | 3.34% |
Log In |
Log In |
Log In |
Log In |
| Scandinavia | 168.70M |
Log In |
Log In |
Log In |
Log In |
| Scandinavia Growth | 13.07% |
Log In |
Log In |
Log In |
Log In |
| Other Europe | 440.70M |
Log In |
Log In |
Log In |
Log In |
| Other Europe Growth | 20.48% |
Log In |
Log In |
Log In |
Log In |
| North America | 376.70M |
Log In |
Log In |
Log In |
Log In |
| North America Growth | 101.44% |
Log In |
Log In |
Log In |
Log In |
| Other Markets | 253.10M |
Log In |
Log In |
Log In |
Log In |
| Other Markets Growth | 40.22% |
Log In |
Log In |
Log In |
Log In |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Human Pharmaceuticals (Hospital and Pharmacy Channel) Reported Market Share |
Log In |
Log In |
Log In |
Log In |
| Reference Priced Prescription Drugs (Pharmacy Channel) Reported Market Share |
Log In |
Log In |
Log In |
Log In |
| Self-Care Products (Pharmacy Channel) Reported Market Share |
Log In |
Log In |
Log In |
Log In |
| Prescription Drugs (Pharmacy Channel) Reported Market Share |
Log In |
Log In |
Log In |
Log In |